News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,248 Results
Type
Article (86411)
Company Profile (651)
Press Release (759186)
Multimedia
Podcasts (131)
Webinars (14)
Section
Business (232646)
Career Advice (4127)
Deals (39721)
Drug Delivery (129)
Drug Development (90939)
Employer Resources (198)
FDA (18089)
Job Trends (17338)
News (396347)
Policy (39736)
Tag
Academia (2998)
Academic (1)
Accelerated approval (6)
Adcomms (26)
Allergies (93)
Alliances (56833)
ALS (103)
Alzheimer's disease (1499)
Antibody-drug conjugate (ADC) (158)
Approvals (18057)
Artificial intelligence (306)
Autoimmune disease (28)
Automation (16)
Bankruptcy (403)
Best Places to Work (12620)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (448)
Bladder cancer (82)
Brain cancer (30)
Breast cancer (306)
Cancer (2444)
Cardiovascular disease (207)
Career advice (3534)
Career pathing (34)
CAR-T (173)
Cell therapy (487)
Cervical cancer (21)
Clinical research (73412)
Collaboration (924)
Company closure (2)
Compensation (569)
Complete response letters (28)
COVID-19 (2863)
CRISPR (50)
C-suite (271)
Cystic fibrosis (107)
Data (2357)
Decentralized trials (2)
Denatured (46)
Depression (52)
Diabetes (285)
Diagnostics (6914)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (132)
Drug pricing (123)
Drug shortages (29)
Duchenne muscular dystrophy (103)
Earnings (96944)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (130097)
Executive appointments (774)
FDA (19500)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (818)
Gene editing (125)
Generative AI (27)
Gene therapy (361)
GLP-1 (839)
Government (5162)
Grass and pollen (5)
Guidances (150)
Healthcare (20868)
Huntington's disease (26)
IgA nephropathy (30)
Immunology and inflammation (147)
Indications (30)
Infectious disease (3016)
Inflammatory bowel disease (158)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (101)
Interviews (813)
IPO (17826)
IRA (48)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (562)
Leadership (23)
Legal (10102)
Liver cancer (82)
Lung cancer (342)
Lymphoma (160)
Machine learning (9)
Management (65)
Manufacturing (360)
MASH (80)
Medical device (14617)
Medtech (14622)
Mergers & acquisitions (22443)
Metabolic disorders (777)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (113)
Neuropsychiatric disorders (33)
Neuroscience (2100)
NextGen: Class of 2025 (7667)
Non-profit (5080)
Now hiring (41)
Obesity (414)
Opinion (273)
Ovarian cancer (83)
Pain (101)
Pancreatic cancer (91)
Parkinson's disease (158)
Partnered (23)
Patents (254)
Patient recruitment (119)
Peanut (51)
People (65297)
Pharmaceutical (133)
Pharmacy benefit managers (22)
Phase I (22661)
Phase II (31889)
Phase III (24009)
Pipeline (1387)
Policy (175)
Postmarket research (3551)
Preclinical (10231)
Press Release (72)
Prostate cancer (112)
Psychedelics (37)
Radiopharmaceuticals (267)
Rare diseases (425)
Real estate (7392)
Recruiting (75)
Regulatory (26792)
Reports (58)
Research institute (2653)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (80)
Series A (143)
Series B (94)
Service/supplier (27)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4294)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (54)
The Weekly (83)
Vaccines (812)
Venture capitalists (45)
Weight loss (288)
Women's health (41)
Worklife (20)
Date
Last 7 days (970)
Last 30 days (3091)
Last 365 days (34356)
2025 (12314)
2024 (37612)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1270)
Alabama (61)
Alaska (7)
Arizona (267)
Arkansas (14)
Asia (50147)
Australia (8832)
California (6629)
Canada (2099)
China (570)
Colorado (285)
Connecticut (298)
Delaware (164)
Europe (114976)
Florida (974)
Georgia (224)
Hawaii (1)
Idaho (64)
Illinois (626)
India (29)
Indiana (333)
Iowa (12)
Japan (176)
Kansas (113)
Kentucky (26)
Louisiana (14)
Maine (67)
Maryland (985)
Massachusetts (5047)
Michigan (237)
Minnesota (428)
Mississippi (2)
Missouri (92)
Montana (30)
Nebraska (26)
Nevada (69)
New Hampshire (67)
New Jersey (1858)
New Mexico (30)
New York (1861)
North Carolina (1136)
North Dakota (9)
Northern California (2860)
Ohio (221)
Oklahoma (15)
Oregon (46)
Pennsylvania (1456)
Puerto Rico (14)
Rhode Island (35)
South America (1653)
South Carolina (26)
South Dakota (1)
Southern California (2460)
Tennessee (108)
Texas (988)
United States (25217)
Utah (196)
Virginia (168)
Washington D.C. (70)
Washington State (606)
West Virginia (3)
Wisconsin (60)
846,248 Results for "mission bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mission Bio and Integrated DNA Technologies Partner to Advance Single-Cell Precision in CRISPR Genome Editing Analysis
May 7, 2025
·
5 min read
Pipeline
Mission Nixes Preclinical Studies, Falls Back on Clinical Candidates
Mission Therapeutics is down to its clinical assets MTX652 and MTX325, which work by disabling a key enzyme that interferes with the cell’s normal process of removing faulty or dysfunctional mitochondria.
February 28, 2025
·
2 min read
·
Tristan Manalac
C-suite
Stoffels To Depart Galapagos, Short of Five-Year Mission To Remake the Biotech
Paul Stoffels left his perch as J&J’s chief scientific officer in 2022 to replace Galapagos’ founding CEO Onno van de Stolpe, inheriting a company that had suffered a series of clinical failures since its 1999 creation.
April 22, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Mastercard and Apple, and High-Impact Industry Leaders to Advance BioVie Mission and Growth
May 6, 2025
·
11 min read
Biotech Bay
Mission Bio Announces Launch of First Single-Cell Multiple Myeloma Multiomics Solution Aimed to Transform Translational Research and Therapy Development
Mission Bio today announced the launch of the Tapestri® Single-cell Multiple Myeloma Multiomics Solution.
June 4, 2024
·
5 min read
Biotech Beach
Mission Bio’s Tapestri Platform Unveils Insights into Targeted Therapy and Residual Disease Assessment for Multiple Myeloma
Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, announced a new publication led by Hervé Avet-Loiseau, MD, PhD, revealing new insights into disease progression of multiple myeloma.
April 30, 2024
·
4 min read
Biotech Bay
Mission Bio’s New Translocation Analysis Offers Insights into Critical Safety Assessment for Gene-Edited Cell Products
Mission Bio today announced the launch of a new single-cell capability that enhances our understanding of translocations (chromosomal rearrangements) in gene-edited therapies.
April 25, 2024
·
4 min read
Press Releases
Biophytis Announces New Non-Clinical Data Further Supporting Its Mission to Pioneer the Restoration of Mobility in Patients with Obesity
March 24, 2025
·
4 min read
Press Releases
INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update
May 9, 2025
·
12 min read
Biotech Bay
Mission Bio Launches Sample Multiplexing for Tapestri to Unlock Critical Single-Cell Insights for Oncology and Genome Editing Markets
Mission Bio , a leader in single-cell multiomic solutions for precision medicine, today introduces sample multiplexing features for the company’s Tapestri Platform.
April 4, 2024
·
4 min read
1 of 84,625
Next
